Company · CIK 0001936258 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
NewAmsterdam Pharma Co N.V. · NAMS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 PForm 4 → | Sep 15, 4:30 pm EDT | Michael H. DavidsonChief Executive Officer, Director | 10,000 | $22.65 | $226,500 | 792,923 | +1.28% | |
| Sep 4, 2026 SForm 4 → | Sep 9, 4:30 pm EDT | John W SmitherDirector | 1,600 | $25.32 | $40,512 | 8,760 | −15.4% | |
| Sep 1, 2026 AForm 4 → | Sep 3, 4:30 pm EDT | Robert William GunningVice President, Controller | 3,200 | — | — | 3,200 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 3, 4:30 pm EDT | Robert William GunningVice President, Controller | 14,000 | — | — | 14,000 | — |